Phenotypic and functional characterization of long-term culture- initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor

Blood

Volumn 88, Issue 6, 1996, Pages 2033-2042

  Prosper, Felipe ^b   Stroncek, David ^b   Verfaillie, Catherine M ^a  

^a Division of Hematology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; HLA DR ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BONE MARROW CELL; BURST FORMING UNIT E; COLONY FORMING UNIT GM; FLUORESCENCE ACTIVATED CELL SORTER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOPHENOTYPING; MONONUCLEAR CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0029815705     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.2033.bloodjournal8862033     Document Type: Article

References (42)

1. Goodman JW, Hodgson GS: Evidence for stem cells in the peripheral blood of mice. Blood 19:702, 1962
2. Storb R, Graham TC, Epstein RB, Sale GE, Thomas ED: Demonstration of hematopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 50:537, 1977
3. McCredie KB, Hersh EM, Freireich EJ: Cells capable of colony formation in the peripheral blood of man. Science 171:293, 1970
4. Chervenick PA, Boggs DR: In vitro growth of granulocytic and mononuclear cell colonies from blood of normal individuals. Blood 37:131, 1971
5. Clarke BJ, Housman D: Characterization of an erythroid precursor cell of high proliferative capacity in normal human peripheral blood. Proc Natl Acad Sci USA 74:1105, 1977
6. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM: Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563, 1989
7. Udomsakdi C, Lansdorp PM, Hogge DE, Reid DS, Eaves AC, Eaves CJ: Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood 80:2513, 1992
8. Pettengell R, Luft T, Henschler R, Hows JM, Dexter TM, Ryder D, Testa NG: Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood 84:3653, 1994
9. +-selected human peripheral blood progenitor cells. Blood 84:2898, 1994
10. Dooley DC, Law P: Detection and quantitation of long-term culture-initiating cells in normal human peripheral blood. Exp Hematol 20:156, 1992
11. Kessinger A, Armitage JO, Landmark JD: Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 71:723, 1988
12. Juttner CA, To HO, Ho JK, Bardy PG, Dyson PG, Haylock DN, Kimber RJ: Early hematopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplant Proc 20:40, 1988
13. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
14. Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
15. Richman CM, Weiner RS, Yankee RA: Increase in circulating stem cells following chemotherapy in man. Blood 47:1030, 1976
16. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM: Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony stimulating factor. Blood 74:1905, 1989
17. Gianni AM, Siena S, Bregni, Tarella C, Stern AC, Pileri A, Bonadonna G: Granulocyte-macrophage colony stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation: Lancet 2:580, 1989
18. Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clarke E, Clift R, Hansen J, Shields T, Storb R, Weaver C, Weiden P, Buckner CD: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993
19. + progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor. Exp Hematol 22:990, 1994
20. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick A, Moubayed M, Oldham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitors cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplant. Blood 85:275, 1995
21. Fujisaki T, Otsuka T, Harada M, Ohno Y, Niho Y: Granulocyte colony-stimulating factor mobilizes primitive hematopoietic stem cells in normal individuals. Bone Marrow Transplant 16:57, 1195
22. Sutherland HJ, Eaves CJ, Lansdorp PM, Phillips GL, Hogge DE: Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplantation. Blood 83:3808, 1994
23. Tong J, Hoffman R, Siena S, Srour RF, Bregni M, Gianni AM: Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts. Exp Hematol 22:1016, 1994
24. Widman FK: Standards for Blood Bank and Transfusion Services (ed 15). Bethesda, MD, American Association of Blood Banks, 1993
25. Sutherland RD, Keating A, Nayar R, Anania S, Stewart K: Sensitive detection and enumeration of CD3.4+ cells in peripheral and cord blood by flow cytometry. Exp Hematology 22:1003, 1994
26. Verfaillie C, McGlave P: Leukemia inhibitory factor/human interleukin for DA cells: A growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors. Blood 77:263, 1991
27. Verfaillie C, Blakholmer K, McGlave P: Purified primitive human hematopoietic progenitors with long term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 172:509, 1990
28. Burrhoughs JM, Gupta P, Verfaillie CM: Soluble factors from the mouse fibroblast cell line M210-B4 support in vitro hematopoiesis. Exp Hematol 2:1095, 1994
29. Sutherland HJ, Eaves CJ, Lansdorp PM, Thaker JD, Hogge DE: Differential regulation of primitive human hematopoietic cells in long-term marrow cultures maintained on genetically engineered murine stromal cells. Blood 78:666, 1991
30. Taswell C: Limiting dilution assays for the determination of immunocompetent cell frequencies: 1, Data analysis. J Immunol 126:1614, 1981
31. Bhatia R, McGlave PB, Dewald GW, Blazar BR, Verfaillie CM: Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: Role of malignant stromal macrophages. Blood 85:3636, 1995
32. Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ: Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87:3584, 1990
33. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral blood progenitors and growth factors after engrafment. J Clin Oncol 12:28, 1994
34. Haas R, Witt B, Mohle H, Goldschmidt H, Hohaus S, Fruehauf M, Wannenmacher M, Hunstein W: Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 85:3754, 1995
35. + hematopoietic stem cells. Blood 83:3758, 1994
36. Zijlmans JM, Visser JW, Kleiverda K, Kluin PM, Willemze R, Fibbe WE: Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc Natl Acad Sci USA 92:8901, 1995
37. Bender JG, To LB, Willians S, Schwartzberg LS: Defining a therapeutic dose of peripheral blood of stem cells. J Hematotherapy 1:329, 1992
38. Roberts AW, DeLuca E, Begley CG, Basser R, Grigg AP, Metcalf D: Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells 13:512, 1995
39. + cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Clin Immunol Immunopathol 70:10, 1994
40. Saeland S, Duvert V, Caux C, Pandrau D, Favre C, Valle A, Durand I, Charbord P, de Vries J, Banchereau J: Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Exp Hematol 20:24, 1992
41. + cells. Blood 84:2930, 1994
42. Verfaillie CM, Catanzarro PM, Li WN. Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med 179:643, 1994